85 related articles for article (PubMed ID: 8390159)
1. Attempts to use alpha-melanotropin-containing melphalan in melanoma patients.
Lejeune FJ; Ghanem GE
Ann N Y Acad Sci; 1993 May; 680():391-400. PubMed ID: 8390159
[No Abstract] [Full Text] [Related]
2. [111In]DTPA-labeled analogues of alpha-MSH for the detection of MSH receptors in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Ann N Y Acad Sci; 1993 May; 680():445-7. PubMed ID: 8390165
[No Abstract] [Full Text] [Related]
3. Human melanoma targeting with alpha-MSH-melphalan conjugate.
Ghanem GE; Libert A; Arnould R; Vercammen A; Lejeune F
Melanoma Res; 1991; 1(2):105-14. PubMed ID: 1668532
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells.
Adams G; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Ann N Y Acad Sci; 1993 May; 680():440-1. PubMed ID: 8390163
[No Abstract] [Full Text] [Related]
5. Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.
Giblin MF; Wang N; Hoffman TJ; Jurisson SS; Quinn TP
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):12814-8. PubMed ID: 9788997
[TBL] [Abstract][Full Text] [Related]
6. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
7. Receptor-mediated cytotoxicity of alpha-MSH fragments containing melphalan in a human melanoma cell line.
Morandini R; Süli-Vargha H; Libert A; Loir B; Botyánszki J; Medzihradszky K; Ghanem G
Int J Cancer; 1994 Jan; 56(1):129-33. PubMed ID: 8262669
[TBL] [Abstract][Full Text] [Related]
8. Receptor binding and cytotoxicity studies with melanotropin fragments containing melphalan.
Süli-Vargha H; Ghanem G; Morandini R; Libert A; Botyánszki J; Medzihradszky K
Ann N Y Acad Sci; 1993 May; 680():616-8. PubMed ID: 8390204
[No Abstract] [Full Text] [Related]
9. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
[TBL] [Abstract][Full Text] [Related]
10. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
[TBL] [Abstract][Full Text] [Related]
11. Receptors for melanocyte-stimulating hormone on melanoma cells.
Eberle AN; Siegrist W; Bagutti C; Chluba-De Tapia J; Solca F; Wikberg JE; Chhajlani V
Ann N Y Acad Sci; 1993 May; 680():320-41. PubMed ID: 8390156
[No Abstract] [Full Text] [Related]
12. Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.
Froidevaux S; Calame-Christe M; Tanner H; Eberle AN
J Nucl Med; 2005 May; 46(5):887-95. PubMed ID: 15872364
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.
Eberle AN; Froidevaux S
J Mol Recognit; 2003; 16(5):248-54. PubMed ID: 14523936
[TBL] [Abstract][Full Text] [Related]
14. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of the MSH receptor among B16 murine melanoma subclones.
Solcà FF; Salomon Y; Eberle AN
J Recept Res; 1991; 11(1-4):379-90. PubMed ID: 1653343
[TBL] [Abstract][Full Text] [Related]
16. Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ.
Tatro JB; Entwistle ML; Lester BR; Reichlin S
Cancer Res; 1990 Feb; 50(4):1237-42. PubMed ID: 2153454
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
[TBL] [Abstract][Full Text] [Related]
18. A cleavable biotinylated photoactivable derivative of alpha-MSH. Its application to the characterization and isolation of the alpha-MSH receptor.
Ahmed AR; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Ann N Y Acad Sci; 1993 May; 680():442-4. PubMed ID: 8390164
[No Abstract] [Full Text] [Related]
19. alpha-MSH receptor autoradiography on mouse and human melanoma tissue sections and biopsies.
Bagutti C; Oestreicher M; Siegrist W; Oberholzer M; Eberle AN
J Recept Signal Transduct Res; 1995; 15(1-4):427-42. PubMed ID: 8903955
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and receptor binding analysis of thirteen oligomeric alpha-MSH analogs.
Brandenburger Y; Rose K; Bagutti C; Eberle AN
J Recept Signal Transduct Res; 1999; 19(1-4):467-80. PubMed ID: 10071778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
